Tela Bio Inc

NASDAQ TELA

Data sourced from

and

Download Data

Tela Bio Inc Revenue Per Share for the year ending December 31, 2023: USD 2.56

Tela Bio Inc Revenue Per Share is USD 2.56 for the year ending December 31, 2023, a 0.39% change year over year. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors.

Tela Bio Inc Revenue Per Share for the year ending December 31, 2022 was USD 2.55, a 25.07% change year over year.
Tela Bio Inc Revenue Per Share for the year ending December 31, 2021 was USD 2.04, a 44.57% change year over year.
Tela Bio Inc Revenue Per Share for the year ending December 31, 2020 was USD 1.41, a -83.90% change year over year.
Tela Bio Inc Revenue Per Share for the year ending December 31, 2019 was USD 8.74, a 585.66% change year over year.

NASDAQ: TELA

Tela Bio Inc

CEO	Mr. Antony Koblish
IPO Date	Nov. 8, 2019
Location	United States
Headquarters	1 Great Valley Parkway, Malvern, PA, United States, 19355
Employees	227
Sector	Healthcare
Industry	Medical devices

Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Key trends